Pfizer Inc (PFE) CEO receives grant of 23 phantom stock units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

BOURLA ALBERT reported acquisition or exercise transactions in this Form 4 filing.

PFIZER INC Chairman & CEO Albert Bourla reported a compensation-related grant of 23 Phantom Stock Units SSP linked to common stock. The units were awarded at a reference price of $26.18 per unit and increase his directly held phantom stock balance to 772,789 units.

Each phantom unit represents one phantom share of Pfizer common stock and is part of the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan. These units are settled in cash after his separation from service and may be moved into an alternative investment account at any time, so they do not represent an open-market stock purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BOURLA ALBERT

Role Chairman & CEO

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units SSP	23	$26.18	$602.14

Holdings After Transaction: Phantom Stock Units SSP — 772,789 shares (Direct, null)

Footnotes (1)

Each unit represents one phantom share of common stock. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Key Figures

Phantom units granted: 23 units Grant reference price: $26.18 per unit Phantom units after grant: 772,789 units +1 more

4 metrics

Phantom units granted 23 units Phantom Stock Units SSP granted on May 29, 2026

Grant reference price $26.18 per unit Reference price for Phantom Stock Units SSP

Phantom units after grant 772,789 units Total Phantom Stock Units directly held after transaction

Underlying common stock linkage 1 unit : 1 share Each unit represents one phantom share of common stock

Key Terms

Phantom Stock Units SSP, Nonfunded Deferred Compensation and Supplemental Savings Plan, phantom share, cash settled

4 terms

Phantom Stock Units SSP financial

"Phantom Stock Units SSP linked to common stock."

Nonfunded Deferred Compensation and Supplemental Savings Plan financial

"acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan"

cash settled financial

"are settled in cash following the reporting person's separation from service"

A contract described as cash settled is one where, at the end, one party pays the monetary difference in value rather than delivering the actual underlying asset. For investors this matters because it simplifies transactions (like settling a bet by paying the win amount instead of handing over a physical item), affects liquidity and timing of cash flows, and changes exposure to storage, delivery logistics and certain tax or counterparty considerations.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/01/2026 - 07:42 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOURLA ALBERT

(Last)

(First)

(Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK

10001-2192

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chairman & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Phantom Stock Units SSP	⁽¹⁾	05/29/2026		A		23		⁽²⁾	⁽²⁾	Common Stock	23	$26.18	772,789	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

	/s/ Esther H. Louis, by power of attorney, for Albert Bourla	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Pfizer (PFE) CEO Albert Bourla report in this Form 4 filing?

Albert Bourla reported a grant of 23 Phantom Stock Units SSP linked to Pfizer common stock. These units are part of a deferred compensation plan and increase his phantom stock balance rather than reflecting an open-market share purchase or sale.

Are Albert Bourla’s reported Phantom Stock Units in Pfizer (PFE) settled in stock or cash?

The Phantom Stock Units are settled in cash after Albert Bourla’s separation from service. Each unit tracks one phantom share of Pfizer common stock but does not result in actual share delivery, functioning as a cash-settled deferred compensation instrument.

What price and quantity were involved in Albert Bourla’s Pfizer (PFE) phantom unit grant?

Albert Bourla received 23 Phantom Stock Units SSP at a reference price of $26.18 per unit. This small award adds to his existing phantom unit holdings within Pfizer’s Nonfunded Deferred Compensation and Supplemental Savings Plan structure.

How many Pfizer (PFE) phantom stock units does Albert Bourla hold after this transaction?

Following the grant, Albert Bourla holds 772,789 Phantom Stock Units directly. These units mirror Pfizer common stock performance but are part of a cash-settled deferred compensation arrangement, rather than representing currently exercisable equity or tradable shares.

Can Albert Bourla change how his Pfizer (PFE) Phantom Stock Units are invested?

Yes. The filing notes that the Phantom Stock Units may be transferred by Albert Bourla into an alternative investment account at any time. This flexibility applies within the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan framework.